XOMA - XOMA Corporation Stock Price and Quote

XOMA [NASD]

Index	-	P/E	-	EPS (ttm)	-1.98	Insider Own	0.20%	Shs Outstand	11.46M	Perf Week	-6.91%
Market Cap	237.05M	Forward P/E	-	EPS next Y	-0.34	Insider Trans	194.25%	Shs Float	11.38M	Perf Month	-10.05%
Income	-22.60M	PEG	-	EPS next Q	-0.49	Inst Own	59.10%	Short Float / Ratio	3.85% / 14.60	Perf Quarter	3.48%
Sales	6.00M	P/S	39.51	EPS this Y	-402.70%	Inst Trans	0.88%	Short Interest	0.44M	Perf Half Y	4.04%
Book/sh	10.82	P/B	1.81	EPS next Y	64.60%	ROA	-14.40%	Target Price	62.50	Perf Year	-35.12%
Cash/sh	6.52	P/C	3.01	EPS next 5Y	19.00%	ROE	-16.50%	52W Range	15.68 - 32.08	Perf YTD	4.38%
Dividend	-	P/FCF	-	EPS past 5Y	-36.40%	ROI	-14.00%	52W High	-40.14%	Beta	0.84
Dividend %	-	Quick Ratio	14.70	Sales past 5Y	-35.20%	Gross Margin	-	52W Low	22.48%	ATR	1.11
Employees	12	Current Ratio	14.70	Sales Q/Q	-95.80%	Oper. Margin	-	RSI (14)	37.79	Volatility	5.37% 5.12%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-138.00%	Profit Margin	-	Rel Volume	0.60	Prev Close	19.64
Shortable	Yes	LT Debt/Eq	0.00	Earnings	-	Payout	-	Avg Volume	30.03K	Price	19.20
Recom	2.50	SMA20	-9.32%	SMA50	-9.14%	SMA200	-3.11%	Volume	4,869	Change	-2.21%

Sep-07-21

Downgrade

Wedbush

Outperform → Neutral

$22

Jun-29-21

Initiated

Aegis Capital

Buy

$60

Jan-19-21

Reiterated

H.C. Wainwright

Buy

$30 → $56

Jan-18-18

Reiterated

H.C. Wainwright

Buy

$38 → $49

Oct-17-17

Resumed

H.C. Wainwright

Buy

$38

Sep-05-17

Upgrade

Wedbush

Neutral → Outperform

$9 → $19

Jun-12-17

Initiated

H.C. Wainwright

Buy

$15

Nov-14-16

Downgrade

Wedbush

Outperform → Neutral

$17 → $14

Mar-11-16

Reiterated

Wedbush

Outperform

$6 → $3

Jul-23-15

Downgrade

Jefferies

Buy → Hold

Show Previous Ratings

Mar-21-23 07:30AM	XOMA Declares Quarterly Preferred Stock Dividends GlobeNewswire
Mar-10-23 05:36AM	XOMA Full Year 2022 Earnings: Revenues Beat Expectations, EPS In Line Simply Wall St.
Mar-09-23 07:30AM	XOMA Reports Full-Year 2022 Financial Results and Provides Update to the Acceleration of its Differentiated Royalty Monetization Strategy GlobeNewswire +5.76%
Mar-06-23 08:28AM	XOMA Corporation's (NASDAQ:XOMA) largest shareholders are individual investors with 37% ownership, hedge funds own 32% Simply Wall St.
Feb-28-23 07:30AM	XOMA to Present at 43rd Annual Cowen Health Care Conference GlobeNewswire
07:00PM	Loading…
Jan-06-23 07:00PM	XOMA Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Jan-04-23 07:30AM	New Executive Leadership Team Appointed to Accelerate XOMAs Differentiated Royalty Monetization Strategy GlobeNewswire
Dec-22-22 07:30AM	XOMA Declares Quarterly Preferred Stock Dividends GlobeNewswire
Dec-07-22 07:44AM	XOMA (NASDAQ:XOMA) shareholders have endured a 39% loss from investing in the stock five years ago Simply Wall St.
Nov-22-22 07:01AM	XOMA Acquires Royalty and Milestone License to Ebopiprant, a Preterm Labor Asset, Being Developed by Organon GlobeNewswire +15.91%
Nov-06-22 09:24AM	XOMA Corporation's (NASDAQ:XOMA) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong? Simply Wall St.
Nov-03-22 09:05AM	Xoma (XOMA) Reports Q3 Loss, Misses Revenue Estimates Zacks
07:30AM	XOMA Reports Third Quarter 2022 Financial Results and Highlights Recent Operational Events GlobeNewswire
Sep-27-22 08:30AM	Hedge funds own 31% of XOMA Corporation (NASDAQ:XOMA) shares but individual investors control 40% of the company Simply Wall St.
Sep-21-22 07:30AM	XOMA Declares Quarterly Preferred Stock Dividends GlobeNewswire
07:30AM	Loading…
Sep-07-22 07:30AM	XOMA to Present at H.C. Wainwright 24th Annual Global Investment Conference GlobeNewswire
Sep-01-22 06:20AM	Is There An Opportunity With XOMA Corporation's (NASDAQ:XOMA) 49% Undervaluation? Simply Wall St. -7.34%
Aug-11-22 06:22AM	Time To Worry? Analysts Are Downgrading Their XOMA Corporation (NASDAQ:XOMA) Outlook Simply Wall St.
Aug-04-22 10:45AM	Xoma (XOMA) Reports Q2 Loss, Misses Revenue Estimates Zacks -6.64%
07:30AM	XOMA Reports Second Quarter 2022 Financial Results and Highlights Recent Operational Events GlobeNewswire
Jun-30-22 07:33AM	Investing in XOMA (NASDAQ:XOMA) five years ago would have delivered you a 196% gain Simply Wall St. +8.95%
Jun-20-22 07:30AM	XOMA Declares Quarterly Preferred Stock Dividends GlobeNewswire
Jun-02-22 01:00AM	Kuros Biosciences: Completion of the Acquisition of Checkmate Pharmaceuticals by Regeneron Pharmaceuticals Triggers a $5 Million Milestone Payment GlobeNewswire
May-30-22 07:06AM	Is Weakness In XOMA Corporation (NASDAQ:XOMA) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects? Simply Wall St.
May-17-22 04:05PM	XOMA to Present at H.C. Wainwright Global Investment Conference GlobeNewswire
May-07-22 08:27AM	This Just In: Analysts Are Boosting Their XOMA Corporation (NASDAQ:XOMA) Outlook for This Year Simply Wall St.
May-05-22 08:55AM	Xoma (XOMA) Reports Q1 Loss, Misses Revenue Estimates Zacks
07:30AM	XOMA Reports First Quarter 2022 Financial Results and Highlights Recent Operational Events GlobeNewswire
May-03-22 08:15AM	Kymera Therapeutics, Inc. (KYMR) Reports Q1 Loss, Lags Revenue Estimates Zacks
Apr-20-22 08:24AM	What Is The Ownership Structure Like For XOMA Corporation (NASDAQ:XOMA)? Simply Wall St.
07:30AM	Loading…
Mar-21-22 07:30AM	XOMA Declares Quarterly Preferred Stock Dividends GlobeNewswire
Mar-15-22 06:21AM	XOMA Corporation's (NASDAQ:XOMA) 32% Share Price Surge Not Quite Adding Up Simply Wall St.
Mar-10-22 09:43AM	XOMA Corporation (NASDAQ:XOMA) Shares Could Be 20% Below Their Intrinsic Value Estimate Simply Wall St.
07:30AM	XOMA to Present at Oppenheimers 32nd Annual Healthcare Conference GlobeNewswire
Mar-08-22 07:30AM	XOMA Reports Full Year 2021 Financial Results and Highlights Recent Operational Events GlobeNewswire +11.47%
Mar-01-22 07:30AM	XOMA to Present at the 42nd Annual Cowen Health Care Conference GlobeNewswire
Feb-17-22 07:30AM	XOMA to Present at Aegis Capital Corp Investor Conference GlobeNewswire
Jan-21-22 10:21AM	XOMA's (NASDAQ:XOMA) investors will be pleased with their massive 368% return over the last five years Simply Wall St.
Dec-23-21 07:30AM	XOMA Declares Quarterly Preferred Stock Dividends GlobeNewswire
Dec-21-21 07:30AM	XOMA to Present at Upcoming Investor Conferences GlobeNewswire +7.94%
Dec-16-21 07:30AM	XOMA Announces Evolution of Company Leadership and Succession Planning GlobeNewswire
Nov-22-21 11:46AM	Should Weakness in XOMA Corporation's (NASDAQ:XOMA) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? Simply Wall St.
Nov-15-21 06:01AM	10 Best Biotech Stocks to Buy According to Mark Lamperts Biotechnology Value Fund Insider Monkey
Nov-04-21 10:15AM	Xoma (XOMA) Reports Q3 Loss, Misses Revenue Estimates Zacks
07:40AM	XOMA Earns $35 Million Milestone Payment as Anti-TGF Antibody Enters Phase 3 Clinical Study in Metastatic Pancreatic Cancer GlobeNewswire
07:30AM	XOMA Reports Third Quarter 2021 Financial Results and Highlights Recent Operational Events GlobeNewswire
Oct-28-21 03:06PM	Will Xoma (XOMA) Report Negative Q3 Earnings? What You Should Know Zacks
Oct-27-21 04:50AM	10 Pharma Stocks to Buy According to Mark Lamperts Biotechnology Value Fund Insider Monkey
Oct-14-21 06:57AM	10 Pharmaceutical Stocks to Buy According to Timothy Lynchs Stonepine Capital Insider Monkey
Oct-08-21 03:35AM	Strength Seen in Xoma (XOMA): Can Its 11.2% Jump Turn into More Strength? Zacks +8.96%
Sep-22-21 07:30AM	XOMA to Present at the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference GlobeNewswire
Sep-21-21 12:33PM	Here's What XOMA Corporation's (NASDAQ:XOMA) Shareholder Ownership Structure Looks Like Simply Wall St.
Sep-20-21 07:30AM	XOMA Declares Quarterly Preferred Stock Dividends GlobeNewswire -6.94%
Sep-13-21 07:30AM	XOMA to Present at H.C. Wainwright 23rd Annual Global Investment Conference GlobeNewswire
Sep-07-21 01:49PM	Why Did Wedbush Downgrade Xoma? Benzinga -12.53%
Aug-10-21 04:35PM	XOMA Announces Heather L. Franklin Joins its Board of Directors GlobeNewswire
Aug-05-21 08:45AM	Xoma (XOMA) Reports Q2 Loss, Misses Revenue Estimates Zacks
07:30AM	XOMA Reports Second Quarter 2021 Financial Results and Highlights Recent Operational Events GlobeNewswire
Jul-29-21 03:05PM	Earnings Preview: Xoma (XOMA) Q2 Earnings Expected to Decline Zacks -5.18%
Jul-28-21 07:30AM	U.S. Food and Drug Administration has Granted Orphan Drug Designation to XOMAs Licensed anti-TGF Asset NIS793 GlobeNewswire
Jul-15-21 06:38AM	XOMA Buys Royalty, Milestone Interest In Checkmate's Vidutolimod From Kuros Biosciences Benzinga
04:17AM	Kuros to receive $7 million up front and potentially $166.5 million in future revenues under a royalty purchase agreement with XOMA related to Kuross license agreement with Checkmate Pharmaceuticals GlobeNewswire
04:00AM	XOMA Acquires Royalty and Milestone Interest in Checkmates Vidutolimod (CMP-001) from Kuros Biosciences GlobeNewswire
Jun-23-21 03:16PM	Is XOMA Corp (XOMA) A Good Stock To Buy? Insider Monkey
Jun-21-21 07:30AM	XOMA Declares Quarterly Preferred Stock Dividends GlobeNewswire
Jun-08-21 10:38AM	XOMA Corporation (NASDAQ:XOMA) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap? Simply Wall St.
May-21-21 08:00AM	XOMA Licensees to Present Significant Clinical Data at 2021 ASCO Annual Meeting GlobeNewswire
May-06-21 09:15AM	Xoma (XOMA) Reports Q1 Loss, Misses Revenue Estimates Zacks -8.73%
07:30AM	XOMA Reports First Quarter 2021 Financial Results and Highlights Recent Operational Events GlobeNewswire
May-03-21 07:30AM	XOMA Earns Milestone for First Patient Dosed in Phase 3 Development Program GlobeNewswire
Apr-15-21 09:05AM	XOMAs Royalty Portfolio Grows with Addition of Three Royalty Assets GlobeNewswire
Apr-12-21 07:30AM	XOMA Announces Closing of Depositary Shares Offering and Exercise of Underwriters Option GlobeNewswire
Apr-06-21 07:02PM	XOMA Prices $35 Million Offering of Depositary Shares GlobeNewswire
Apr-05-21 04:05PM	XOMA Announces Offering of Depositary Shares and Series B Cumulative Perpetual Preferred Stock GlobeNewswire
Mar-23-21 08:00AM	Viracta and XOMA Announce Multi-License Milestone and Royalty Monetization Transaction PR Newswire
Mar-22-21 07:30AM	XOMA Announces Approval of First Preferred Stock Dividend GlobeNewswire
Mar-10-21 08:45AM	Xoma (XOMA) Beats Q4 Earnings and Revenue Estimates Zacks
07:30AM	XOMA Reports Fourth Quarter and Full-Year 2020 Financial Results and Operating Highlights GlobeNewswire
Mar-03-21 05:16AM	What Type Of Shareholders Own The Most Number of XOMA Corporation (NASDAQ:XOMA) Shares? Simply Wall St.
Mar-02-21 12:30PM	Xoma (XOMA) to Report Q4 Results: Wall Street Expects Earnings Growth Zacks
Feb-23-21 04:05PM	XOMA to Present at Upcoming Investor Conferences GlobeNewswire
Jan-04-21 04:05PM	XOMA to Present at H.C. Wainwright Virtual BioConnect 2021 and Biotech Showcase Digital Conferences GlobeNewswire -9.77%
Dec-30-20 05:50AM	What Does XOMA's (NASDAQ:XOMA) CEO Pay Reveal? Simply Wall St.
Dec-21-20 05:00PM	XOMA Announces Exercise of Green Shoe Option and Closes Preferred Stock Offering GlobeNewswire
Dec-10-20 11:45PM	Is XOMA A Good Stock To Buy Now? Insider Monkey +6.66%
06:22PM	XOMA Prices $22 Million Offering of Series A Cumulative Perpetual Preferred Stock GlobeNewswire
07:52AM	XOMA Announces Offering of Series A Cumulative Perpetual Preferred Stock GlobeNewswire
Dec-08-20 08:38AM	XOMA Catches Eye: Stock Jumps 7.9% Zacks
Nov-16-20 07:30AM	XOMA Earns $2 Million Milestone from Takeda as Mezagitamab Advances into Phase 2 Development GlobeNewswire +11.43%
Nov-12-20 09:47AM	Can You Imagine How XOMA's (NASDAQ:XOMA) Shareholders Feel About The 12% Share Price Increase? Simply Wall St.
Nov-11-20 07:30AM	XOMA Earns First Milestone Payment from 2018 Royalty Purchase Agreement GlobeNewswire
Nov-06-20 08:56AM	XOMA's Shares March Higher, Can It Continue? Zacks
Nov-05-20 09:35AM	Xoma (XOMA) Reports Q3 Loss, Misses Revenue Estimates Zacks
07:30AM	XOMA Highlights Recent Royalty Asset Portfolio Developments and Reports Third Quarter 2020 Financial Results GlobeNewswire
Nov-03-20 07:30AM	XOMA Acquires Royalty Interest in Four Lysosomal Storage Disorder Enzymes Being Developed Under the Chiesi GroupBioasis Strategic Alliance GlobeNewswire +8.24%
Oct-28-20 07:30AM	XOMA Earns $25 Million Milestone Payment as Anti-TGF Antibody Enters Phase 2 Clinical Study in Metastatic Pancreatic Cancer GlobeNewswire
Oct-14-20 07:30AM	XOMA Earns $1.9 Million Associated with Two Partner Developments GlobeNewswire
Sep-23-20 12:15PM	Is XOMA Corporation (NASDAQ:XOMA) Popular Amongst Institutions? Simply Wall St.
Sep-10-20 11:18AM	Insider Buys XOMA's Shares Benzinga
Sep-02-20 07:30AM	XOMA to Present at Upcoming Investor Conferences GlobeNewswire

XOMA Corporation operates as a biotech royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with various assets. The company was incorporated in 1981 and is headquartered in Emeryville, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BVF PARTNERS L P/IL	Director	Jan 06	Buy	21.98	3,249	71,419	1,789,844	Jan 09 05:44 PM
BVF PARTNERS L P/IL	Director	Jan 05	Buy	18.39	19,000	349,319	1,788,168	Jan 09 05:44 PM
BVF PARTNERS L P/IL	Director	Sep 27	Buy	16.89	1,682	28,409	1,784,838	Sep 27 07:22 PM
BVF PARTNERS L P/IL	Director	Sep 26	Buy	16.83	6,360	107,050	1,783,834	Sep 27 07:22 PM
BVF PARTNERS L P/IL	Director	Sep 23	Buy	16.50	16,600	273,850	1,780,495	Sep 27 07:22 PM
BVF PARTNERS L P/IL	Director	Sep 16	Buy	17.89	24,293	434,536	1,773,780	Sep 16 06:30 PM
BVF PARTNERS L P/IL	Director	Sep 15	Buy	17.96	5,575	100,138	1,576,913	Sep 16 06:30 PM
BVF PARTNERS L P/IL	Director	Sep 14	Buy	17.25	26,441	456,044	1,571,338	Sep 16 06:30 PM
Neal James R	CEO	Jul 15	Option Exercise	4.03	25,000	100,750	36,822	Jul 18 04:30 PM
BURNS THOMAS M.	SVP, Finance & CFO	Jul 15	Option Exercise	4.03	2,000	8,060	8,555	Jul 18 04:30 PM
Neal James R	CEO	Jul 15	Sale	29.84	25,000	746,104	11,822	Jul 18 04:30 PM
BURNS THOMAS M.	SVP, Finance & CFO	Jul 15	Sale	31.66	2,000	63,321	6,555	Jul 18 04:30 PM
Neal James R	CEO	Mar 23	Option Exercise	4.03	1,111	4,477	12,933	Mar 23 06:52 PM
BURNS THOMAS M.	SVP, Finance & CFO	Mar 23	Option Exercise	4.03	161	649	6,716	Mar 23 06:52 PM
Neal James R	CEO	Mar 23	Sale	30.02	1,111	33,348	11,822	Mar 23 06:52 PM
BURNS THOMAS M.	SVP, Finance & CFO	Mar 23	Sale	30.00	161	4,830	6,555	Mar 23 06:52 PM
BURNS THOMAS M.	SVP, Finance & CFO	Mar 22	Option Exercise	4.03	2,339	9,426	8,894	Mar 23 06:52 PM
Neal James R	CEO	Mar 22	Option Exercise	4.03	2,339	9,426	14,161	Mar 23 06:52 PM
Neal James R	CEO	Mar 22	Sale	30.02	2,339	70,209	11,822	Mar 23 06:52 PM
BURNS THOMAS M.	SVP, Finance & CFO	Mar 22	Sale	30.02	2,339	70,209	6,555	Mar 23 06:52 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Upgrade your FINVIZ experience